 
							
					
															
					
					 by Intelligent Sugar | Oct 21, 2025 | News
Allulose Shows Low Cariogenic Potential in New Oral Microbiome Study A recent study published in Frontiers in Cellular and Infection Microbiology examined how different sugars influence the development of dental biofilms and microbial balance in the mouth. The...				
					
			
					
											
								 
							
					
															
					
					 by Intelligent Sugar | Oct 7, 2025 | News
A recent study published in Nature Metabolism (September 2025) has provided compelling new evidence that the type and combination of sugars commonly found in sugar-sweetened beverages (SSBs) can accelerate the progression and spread of colorectal cancer (CRC). This...				
					
			
					
											
								 
							
					
															
					
					 by Intelligent Sugar | Sep 11, 2025 | News
A major new study suggests that diets high in ultra-processed foods could significantly increase the risk of lung cancer – even after accounting for smoking and other lifestyle factors. Why Ultra-Processed Foods Are Under Scrutiny Ultra-processed foods (UPFs)...				
					
			
					
											
								 
							
					
															
					
					 by Intelligent Sugar | Sep 1, 2025 | News
A recent study in CytoJournal (March 2025) sheds light on how a signaling protein, platelet-derived growth factor subunit B (PDGFB), accelerates lung cancer progression by rewiring sugar metabolism. PDGFB, TKTL1, and the Warburg EffectHealthy cells generate energy...				
					
			
					
											
								 
							
					
															
					
					 by Intelligent Sugar | Aug 19, 2025 | News
In a groundbreaking Nature Cell Biology study published on 8 August 2025, researchers uncovered a striking new role for diet-derived galactose: it can reprogram liver metabolism, boosting antitumour immune responses by preventing CD8⁺ T cell exhaustion. The study...				
					
			
					
											
								 
							
					
															
					
					 by Intelligent Sugar | Aug 12, 2025 | News
A recent article published by MDLinx has neurologists abuzz: GLP-1 receptor agonists—originally developed to manage type 2 diabetes and obesity—are showing significant promise in reducing the risk and progression of Alzheimer’s disease. These findings add to a growing...				
					
						 
Recent Comments